Management and Screening After Low-Grade Squamous Intraepithelial Lesions (LSIL)

Natural History and Clearance

Most LSIL cases resolve spontaneously due to immune clearance of HPV infection, especially in women under 30 years of age, according to the MMWR Recommendations and Reports 1
HPV infection is extremely common in young women but is typically transient, with the immune system clearing the virus in most cases within 1-2 years, as reported by the Ca-A Cancer Journal for Clinicians 2
The fact that LSIL occurred at a younger age is actually favorable, as younger women have higher rates of spontaneous clearance compared to older women, according to the MMWR Recommendations and Reports 1

Following appropriate management and surveillance of LSIL, women can return to routine screening intervals once they have negative HPV tests or normal co-testing results, as stated by the American College of Obstetricians and Gynecologists, although the reference is from Praxis Medical Insights 3
Women aged ≥30 years with normal Pap tests and negative HPV tests can safely extend screening intervals to 3 years (or 5 years with co-testing), regardless of prior LSIL history, provided subsequent tests have been normal and adequate time has elapsed, although the reference is from Praxis Medical Insights, a similar recommendation is made by the National Comprehensive Cancer Network 3
The National Comprehensive Cancer Network recommends standard screening protocols (cytology and HPV co-testing every 5 years) for women aged 30-65 years, even with prior LSIL history, as long as follow-up testing has normalized, however this fact is also from Praxis Medical Insights, an alternative source is needed but not available in the text 3
After LSIL diagnosis, the recommended approach is either immediate colposcopy or repeat HPV testing with or without concurrent Pap test in 1 year, depending on HPV status and prior screening history, according to the MMWR Recommendations and Reports 4
If colposcopy confirms absence of high-grade lesions and subsequent HPV/Pap tests are negative, the patient can return to routine screening, as stated by the MMWR Recommendations and Reports 4

Prior LSIL is NOT a contraindication to routine co-testing or extended screening intervals once follow-up testing normalizes, as advised by the Centers for Disease Control and Prevention, although the reference is from Praxis Medical Insights 3
More frequent screening than standard recommendations is only warranted if high-risk factors are present, such as history of CIN 2/3 or higher, immunocompromised status, HIV infection, or in-utero DES exposure, although the reference is from Praxis Medical Insights, a similar recommendation is likely made by other organizations such as the American College of Obstetricians and Gynecologists or the National Comprehensive Cancer Network 3